We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04573153
Recruitment Status : Unknown
Verified September 2020 by ScandiBio Therapeutics AB.
Recruitment status was:  Recruiting
First Posted : October 5, 2020
Last Update Posted : October 6, 2020
Istanbul Medipol University Hospital
Istanbul Umraniye Training and Research Hospital
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Bagcilar Training and Research Hospital
Kanuni Sultan Suleyman Training and Research Hospital
Alanya Alaaddin Keykubat University Alanya Training and Research Hospital
Canakkale 18 Mart University Health Research and Application Hospital
Monitor CRO
Information provided by (Responsible Party):
ScandiBio Therapeutics AB

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : January 31, 2021
Estimated Study Completion Date : March 31, 2021